Widespread shortages of cancer drugs are forcing doctors to make difficult decisions about how to treat their patients, ...
Now, our nation is experiencing another dangerous supply chain shortage. We aren’t just talking about empty shelves of ...
Editor’s Comment, Nelda Murri, PharmD: The public health consequences of national drug shortages are sobering ... following the announcement of a new drug shortage. One author has estimated ...
As drug shortages reach record levels, thousands of patients are facing delays in receiving treatments for cancer and other ...
A new report from the Senate Committee on Homeland Security and Governmental Affairs said drug shortages, which increased nearly 30 percent from 2021 to 2022, pose health and national security ...
There were 301 active national drug shortages through ... to a recent report written by Sen. Gary Peters, D-Mich., chairman of the Senate Committee on Homeland Security and Governmental Affairs.
Through the first three months of the quarter, there were 301 active national drug shortages ... report written by Sen. Gary Peters, D-Mich., chairman of the Senate Committee on Homeland Security ...
Drug overdose deaths in the US rose to record levels during the Covid-19 pandemic, and a new report from the US Centers ... director of the National Institute on Drug Abuse. As with fentanyl ...
A substantial number of physicians suspect there may be market manipulation behind at least some of the shortages. A report to the ... of an unavailable drug. The risk of errors is increased ...
A recent report from the U.S. Senate Committee on Homeland Security and Governmental Affairs identified 295 active drug shortages ... suppliers could pose a national security risk.
The drug is used to treat inflammatory conditions like arthritis and psoriasis, along with certain types of cancer. Shortages ...
including nearly 50 new shortages that accumulated in the first three months of the year. The last time active drug shortages – including both newly reported and ongoing – were this high was ...
